@article{CCO25404,
author = {De-Jun Liu and Rong Hua and Yong-Wei Sun},
title = {Current treatment status in pancreatic neuroendocrine neoplasms},
journal = {Chinese Clinical Oncology},
volume = {8},
number = {2},
year = {2019},
keywords = {},
abstract = {Pancreatic neuroendocrine neoplasms (P-NENs) are a group of pathologically and clinically heterogeneous tumors. In the past several decades, the incidence has been increasing. In 2010, the WHO presented a new classification dividing P-NENs into well-differentiated neuroendocrine tumors (NETs) and poorly-differentiated neuroendocrine carcinomas (NECs). Surgery is the primary and most important treatment for P-NENs, and is also the only possible curative procedure. By the 2018 NCCN guideline, observation can be considered for },
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/25404}
}